These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 833257

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The inhibitory effects of growth hormone-releasing hormone (GHRH)-antagonist on GHRH, L-dopa, and clonidine-induced GH secretion in normal subjects.
    Hanew K, Tanaka A, Utsumi A, Sugawara A, Abe K.
    J Clin Endocrinol Metab; 1996 May; 81(5):1952-5. PubMed ID: 8626863
    [Abstract] [Full Text] [Related]

  • 23. [A low response of pituitary growth hormone secretion in the patient with diabetes mellitus after intravenous administration of L-dopa (author's transl)].
    Shimoda S, Takemura Y, Ieiri T, Kasai K, Kikuchi T.
    Nihon Naibunpi Gakkai Zasshi; 1975 Jan 20; 51(1):9-17. PubMed ID: 1171032
    [Abstract] [Full Text] [Related]

  • 24. Discordance between growth hormone (GH) responses after GH-releasing hormone and insulin hypoglycemia in myotonic dystrophy.
    Okimura Y, Chihara K, Kita T, Kashio Y, Sato M, Kitajima N, Abe H, Takahashi K, Fujita T.
    J Clin Endocrinol Metab; 1988 Nov 20; 67(5):1074-9. PubMed ID: 3141449
    [Abstract] [Full Text] [Related]

  • 25. L-dopa absorption and the pituitary-hypothalamic axis.
    Boyd AE, Angoff G, Long A, Mager M.
    J Clin Endocrinol Metab; 1978 Dec 20; 47(6):1341-7. PubMed ID: 263355
    [Abstract] [Full Text] [Related]

  • 26. Inhibition of L-dopa induced growth hormone release in normal and diabetic subjects by glucose administration.
    Vigas M, Klimes I, Jurcovicova J, Kolesar P, Repcekova-Jezova D.
    Diabete Metab; 1977 Dec 20; 3(4):257-8. PubMed ID: 598566
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Behavior of HGH after oral administration of L-dopa in normal and obese subjects].
    Carducci Artenisio A, Ragonese F, Albanese MC, Alibrando S, Allegra V.
    Boll Soc Ital Biol Sper; 1974 Aug 30; 50(13):946-52. PubMed ID: 4463984
    [No Abstract] [Full Text] [Related]

  • 29. Transient appearance of a provocative growth hormone response to L-dopa following incomplete adenomectomy in an acromegalic patient.
    Takahara J, Yakushiji W, Yamuchi J, Miyoshi M, Hosogi H.
    J Clin Endocrinol Metab; 1977 Mar 30; 44(3):599-602. PubMed ID: 838854
    [Abstract] [Full Text] [Related]

  • 30. Effect of pyridoxine on human hypophyseal trophic hormone release: a possible stimulation of hypothalamic dopaminergic pathway.
    Delitala G, Masala A, Alagna S, Devilla L.
    J Clin Endocrinol Metab; 1976 Mar 30; 42(3):603-6. PubMed ID: 1254699
    [Abstract] [Full Text] [Related]

  • 31. Effect of L-dopa administration on insulin binding: possible role of growth hormone in regulation of insulin receptor affinity.
    Iwasaki M, Kobayashi M, Ohgaku S, Maegawa H, Shigeta Y.
    Horm Metab Res; 1982 Jul 30; 14(7):342-5. PubMed ID: 6749630
    [Abstract] [Full Text] [Related]

  • 32. Endurance exercise modulates levodopa induced growth hormone release in patients with Parkinson's disease.
    Müller T, Welnic J, Woitalla D, Muhlack S.
    Neurosci Lett; 2007 Jul 11; 422(2):119-22. PubMed ID: 17590511
    [Abstract] [Full Text] [Related]

  • 33. Abnormal growth hormone responsiveness to stimuli in women with active celiac sprue.
    Peracchi M, Molteni N, Cantalamessa L, Bardella MT, Peracchi G, Orsatti A, Faggioli P, Bianchi PA.
    Am J Gastroenterol; 1992 May 11; 87(5):580-3. PubMed ID: 1595643
    [Abstract] [Full Text] [Related]

  • 34. [Reevaluation of the I-dopa test in acromegaly: anatomo-clinical and prognostic correlations].
    De Marinis L, Mancini A, Zuppi P, Fiumara C, Iacona T, Conte G, Fabrizi ML, Valle D, Anile C, Maira G.
    Minerva Chir; 1993 Nov 11; 48(21-22):1337-40. PubMed ID: 8152567
    [Abstract] [Full Text] [Related]

  • 35. Effect of experimentally induced hyperprolactinemia on growth hormone secretion.
    Esquifino AI, Fernández-Ruiz JJ, Cebeira M, Agrasal C, Tresguerres JA, Ramos JA.
    Rev Esp Fisiol; 1987 Dec 11; 43(4):463-8. PubMed ID: 3448711
    [Abstract] [Full Text] [Related]

  • 36. Growth hormone (GH) and prolactin responses to repetitive administration of GH-releasing hormone in acromegaly.
    Losa M, Schopohl J, König A, Müller OA, von Werder K.
    J Clin Endocrinol Metab; 1986 Aug 11; 63(2):475-80. PubMed ID: 3088026
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Growth hormone response to propranolol and L--dopa in obese subjects.
    Barbarine A, De Marinis L, Troncone L.
    Metabolism; 1978 Mar 11; 27(3):275-8. PubMed ID: 628352
    [Abstract] [Full Text] [Related]

  • 40. Growth hormone and prolactin release in acromegalic patients following metergoline administration.
    Delitala G, Masala A, Alagna S, Devilla L, Lotti G.
    J Clin Endocrinol Metab; 1976 Dec 11; 43(6):1382-6. PubMed ID: 1002821
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.